Evidence map›Paper›PMID 8523090›Full record

ArticleJournal of neuro-oncology1995

Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8.

R Yamanaka, R Tanaka, S Yoshida, T Saitoh, K Fujita

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R YamanakaDepartment of Neurosurgery, Niigata University, Japan.
R Tanaka
S Yoshida
T Saitoh
K Fujita

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human glioma cell line, NP-1, expresses IL-8 mRNA and constitutively secretes IL-8 protein. Administration of recombinant IL-8 increased the proliferation of NP-1 cells in a dose-dependent manner. In the presence of anti-IL-8 antiserum, the IL-8 mediated proliferation of NP-1 cell growth was inhibited. Further, NP-1 cell growth was inhibited by transfection of retroviral constructs encoding antisense IL-8 both in vitro and in vivo models. These results suggest that antisense IL-8 gene therapy could be beneficial in gliomas where autocrine stimulation by IL-8 is implicated.

Indexed as

3T3 CellsAnimalsBase SequenceCell DivisionCell LineDNA, ComplementaryGene ExpressionGenetic VectorsGliomaHumansInterleukin-8MaleMiceMice, NudeMolecular Sequence DataOligonucleotides, AntisenseDNA, ComplementaryInterleukin-8Oligonucleotides, AntisenseRecombinant ProteinsRNA, Messenger

Identifiers

PMID8523090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.